Ads
related to: latest research on asthma treatmentsassistantcat.com has been visited by 10K+ users in the past month
consumerhippo.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
The research team at King's College London said the drug was a "game-changer" that could "revolutionise" care. The findings stem from the realisation that not all asthma or COPD attacks are the same.
“Many new monoclonal antibodies and biologic treatments are in development which seem to do a great job to reduce the disease burden of asthma,” says Dr. Bowser. And that’s a reason for all ...
Key companies in the area are heavily investing in research and development to create and commercialize new asthma treatments. For example, in December 2021, Amgen Inc. and AstraZeneca announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE (tezepelumab-ekko), a medication designed as an additional maintenance treatment for ...
After years of analysis, the reports and new scientific research led the FDA in 2020 to add a "black box" warning to the montelukast prescribing label, flagging serious mental health risks like ...
Anti-asthmatic agents, also known as anti-asthma drugs, refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and ...
Tezepelumab, sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma. [5] [7] [8] [9] Tezepelumab blocks thymic stromal lymphopoietin (TSLP), [5] an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation.
Ads
related to: latest research on asthma treatmentsassistantcat.com has been visited by 10K+ users in the past month
consumerhippo.com has been visited by 100K+ users in the past month